Compass Pathways PLC CMPS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/26/23 EST
10.35quote price arrow down-0.37 (-3.45%)
Volume
765
Close
10.72UNCH (UNCH)
Volume
336,262
52 week range
6.54 - 21.50
Loading...
  • Open10.82
  • Day High11.07
  • Day Low10.57
  • Prev Close10.72
  • 52 Week High21.50
  • 52 Week High Date08/08/22
  • 52 Week Low6.54
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap456.421M
  • Shares Out42.58M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta2.29
  • YTD % Change33.5

KEY STATS

  • Open10.82
  • Day High11.07
  • Day Low10.57
  • Prev Close10.72
  • 52 Week High21.50
  • 52 Week High Date08/08/22
  • 52 Week Low6.54
  • 52 Week Low Date05/12/22
  • Market Cap456.421M
  • Shares Out42.58M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta2.29
  • YTD % Change33.5

RATIOS/PROFITABILITY

  • EPS (TTM)-2.04
  • P/E (TTM)-5.25
  • Fwd P/E (NTM)-4.35
  • EBITDA (TTM)-103.088M
  • ROE (TTM)-34.49%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/02/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Compass Pathways PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
COMPASS Pathways plc is a United Kingdom-based mental healthcare company. The Company is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression (TRD). The Company has developed COMP360, which is a psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin. The Company's COMP360 has completed a Phase IIb clinical trial of psilocybin therapy for TRD, in...
George Goldsmith
Chairman of the Board, Chief Executive Officer
Michael Falvey
Chief Financial Officer
Matthew Owens
General Counsel, Chief Legal Officer
Address
3Rd Floor, 1 Ashley Road, Altrincham
Altrincham
WA14 2DT
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
TRDA
Entrada Therapeutics Inc
11.67UNCHUNCH
KOD
Kodiak Sciences Inc
7.91UNCHUNCH
THRX
Theseus Pharmaceuticals Inc
11.80UNCHUNCH
LXRX
Lexicon Pharmaceuticals Inc
2.22UNCHUNCH
KZR
Kezar Life Sciences Inc
6.73UNCHUNCH